These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
245 related items for PubMed ID: 8672735
1. Dose-dependent effects of a nitric oxide biosynthesis inhibitor on hyperdynamic circulation in two models of portal hypertension in conscious rats. Pilette C, Kirstetter P, Sogni P, Cailmail S, Moreau R, Lebrec D. J Gastroenterol Hepatol; 1996 Jan; 11(1):1-6. PubMed ID: 8672735 [Abstract] [Full Text] [Related]
2. Haemodynamic and hormonal responses to long-term inhibition of nitric oxide synthesis in rats with portal hypertension. Pilette C, Moreau R, Sogni P, Kirstetter P, Cailmail S, Pussard E, Lebrec D. Eur J Pharmacol; 1996 Sep 19; 312(1):63-8. PubMed ID: 8891579 [Abstract] [Full Text] [Related]
3. [The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats]. Wu Z, Zhou J, Chen Z, Zhou H, Jiao Z, Kuang Y, Yuan J, Wang Q, Zeng M. Zhonghua Wai Ke Za Zhi; 1998 Mar 19; 36(3):182-6. PubMed ID: 11825365 [Abstract] [Full Text] [Related]
4. Reduced splanchnic vasoconstriction to angiotensin II in conscious rats with biliary cirrhosis. Braillon A, Cailmail S, Gaudin C, Lebrec D. J Hepatol; 1993 Jan 19; 17(1):86-90. PubMed ID: 8445224 [Abstract] [Full Text] [Related]
5. [Role of nitric oxide in alterations of the systemic and splanchnic hemodynamics in a experimental model of portal hypertension]. Albornoz L, Bandi JC, Sánchez S, Spinedi E, Canteros G, De Paula JA, Galdame O, Mastai R. Medicina (B Aires); 1994 Jan 19; 54(1):17-24. PubMed ID: 7990681 [Abstract] [Full Text] [Related]
6. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension. Wu Y, Burns RC, Sitzmann JV. Hepatology; 1993 Dec 19; 18(6):1416-21. PubMed ID: 8244267 [Abstract] [Full Text] [Related]
7. Acute and chronic haemodynamic effects of naftazone in portal hypertensive rats. Sogni P, Yang S, Pilette C, Moreau R, Gadano A, Avenard G, Bloy C, Lebrec D. Eur J Pharmacol; 1998 Feb 26; 344(1):37-43. PubMed ID: 9570445 [Abstract] [Full Text] [Related]
8. Effects of continued NO inhibition on portal hypertensive syndrome after portal vein stenosis in rat. García-Pagán JC, Fernández M, Bernadich C, Pizcueta P, Piqué JM, Bosch J, Rodés J. Am J Physiol; 1994 Dec 26; 267(6 Pt 1):G984-90. PubMed ID: 7810666 [Abstract] [Full Text] [Related]
9. Administration of N omega-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats. Lee FY, Colombato LA, Albillos A, Groszmann RJ. Gastroenterology; 1993 Nov 26; 105(5):1464-70. PubMed ID: 8224649 [Abstract] [Full Text] [Related]
10. Role of PGI2 in the formation and maintenance of hyperdynamic circulatory state of portal hypertensive rats. Wu ZY, Chen XS, Qiu JF, Cao H. World J Gastroenterol; 2005 Feb 07; 11(5):752-5. PubMed ID: 15655838 [Abstract] [Full Text] [Related]
11. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Pizcueta MP, Piqué JM, Bosch J, Whittle BJ, Moncada S. Br J Pharmacol; 1992 Jan 07; 105(1):184-90. PubMed ID: 1596680 [Abstract] [Full Text] [Related]
12. Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol. Lebrec D, Moreau R, Cailmail S, Sogni P, Oberti F, Hadengue A. J Hepatol; 1993 Jan 07; 17(1):102-7. PubMed ID: 8445208 [Abstract] [Full Text] [Related]
13. Splanchnic hyposensitivity to glypressin in a haemorrhage/transfused rat model of portal hypertension: role of nitric oxide and bradykinin. Chu CJ, Wu SL, Lee FY, Wang SS, Chang FY, Lin HC, Chan CC, Lee SD. Clin Sci (Lond); 2000 Dec 07; 99(6):475-82. PubMed ID: 11099389 [Abstract] [Full Text] [Related]
14. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats. Fernández M, García-Pagán JC, Casadevall M, Bernadich C, Piera C, Whittle BJ, Piqué JM, Bosch J, Rodés J. Gastroenterology; 1995 May 07; 108(5):1487-95. PubMed ID: 7537235 [Abstract] [Full Text] [Related]
15. The role of increased nitric oxide in the vascular hyporeactivity to noradrenaline in long-term portal vein ligated rats. Michielsen PP, Boeckxstaens GE, Sys SU, Herman AG, Pelckmans PA. J Hepatol; 1995 Sep 07; 23(3):341-7. PubMed ID: 8550999 [Abstract] [Full Text] [Related]
16. Role of nitric oxide and endothelin-1 in a portal hypertensive rat model. Tsugawa K, Hashizume M, Migou S, Kishihara F, Kawanaka H, Tomikawa M, Tanoue K, Sugimachi K. Scand J Gastroenterol; 2000 Oct 07; 35(10):1097-105. PubMed ID: 11099065 [Abstract] [Full Text] [Related]
17. Nitric oxide and pancreatic islet blood flow after induced portal hypertension in rats. Jansson L, Andersson A. Pancreas; 1997 Apr 07; 14(3):280-4. PubMed ID: 9094159 [Abstract] [Full Text] [Related]
18. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension. Cao H, Xu J, Liu H, Meng FB, Qiu JF, Wu ZY. Hepatobiliary Pancreat Dis Int; 2006 Nov 07; 5(4):564-9. PubMed ID: 17085343 [Abstract] [Full Text] [Related]
19. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction. Moleda L, Trebicka J, Dietrich P, Gäbele E, Hellerbrand C, Straub RH, Sauerbruch T, Schoelmerich J, Wiest R. Gut; 2011 Aug 07; 60(8):1122-32. PubMed ID: 21317421 [Abstract] [Full Text] [Related]
20. Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats. Lee FY, Wang SS, Tsai YT, Lin HJ, Lin HC, Chu CJ, Wu SL, Tai CC, Lee SD. J Hepatol; 1997 Mar 07; 26(3):687-93. PubMed ID: 9075678 [Abstract] [Full Text] [Related] Page: [Next] [New Search]